Immunologic Effectiveness of Maraviroc- and Raltegravir-Containing Regimens (R+M+) versus Raltegravir-Based Regimens That Do Not Include Maraviroc (R+M−)
暂无分享,去创建一个
C. Kovacs | T. Antoniou | M. Loutfy | J. Raboud | D. Su | D. Fletcher | Graham H R Smith | Derek Lee | J. Brunetta | F. Crouzat